BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 238 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $3,390,362 | -45.0% | 667,394 | -35.1% | 0.01% | -58.3% |
| Q4 2023 | $6,160,733 | +308.7% | 1,028,503 | +380.4% | 0.01% | +140.0% |
| Q2 2023 | $1,507,229 | +135.5% | 214,095 | +428.6% | 0.01% | -28.6% |
| Q2 2021 | $640,000 | +36.2% | 40,503 | -12.4% | 0.01% | 0.0% |
| Q1 2021 | $470,000 | -55.4% | 46,252 | -79.1% | 0.01% | -53.3% |
| Q2 2020 | $1,053,000 | +1964.7% | 220,891 | +1388.9% | 0.02% | +650.0% |
| Q4 2019 | $51,000 | – | 14,836 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $50,998,000 | 20.86% |
| RTW INVESTMENTS, LP | 3,458,120 | $29,048,000 | 7.65% |
| ISZO CAPITAL MANAGEMENT LP | 307,366 | $2,582,000 | 4.49% |
| DAFNA Capital Management LLC | 541,128 | $4,545,000 | 3.84% |
| RA Capital Management | 3,489,795 | $29,314,000 | 3.60% |
| EMORY UNIVERSITY | 375,348 | $3,153,000 | 2.98% |
| Ghost Tree Capital, LLC | 1,500,000 | $12,600,000 | 2.35% |
| ACUTA CAPITAL PARTNERS, LLC | 920,310 | $7,731,000 | 1.83% |
| Avoro Capital Advisors LLC | 1,603,001 | $13,465,000 | 1.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,085,236 | $25,916,000 | 1.00% |